Cite
HARVARD Citation
Raffel, J. et al. (2012). 148 The effect of natalizumab and interferon-β on urinary free light chains and anti-EBV nuclear antigen-1 antibodies in relapsing remitting multiple sclerosis. Journal of neurology, neurosurgery and psychiatry. 83 (3), p. e1. [Online].